In vitro and in vivo release of naltrexone from biodegradable depot systems
- PMID: 16455607
- DOI: 10.1080/03639040500388466
In vitro and in vivo release of naltrexone from biodegradable depot systems
Abstract
The aim of this study was to prepare poly(d, l-lactide) (PLA) microspheres containing naltrexone (NTX) by a solvent evaporation method, and to evaluate both in vitro and in vivo release characteristics and histopathological findings of tissue surrounding an implant formulation in rats. This method enabled the preparation of microspheres of regular shape and relatively narrow particle size distribution. The in vitro release profiles of NTX from PLA microspheres showed the release of NTX did not follow zero-order kinetics. An initial burst release was observed, subsequently followed by a nearly constant rate of 0.4% per day after ten days. The cumulative amount of NTX released at the end of 60 days was 80%. Compressed microspheres showed near zero-order sustained release of NTX for 360 days. The plasma NTX levels in rats showed that for compressed microspheres NTX concentrations were constant and exceeded 2 ng/mL for 28 days. Throughout the 28 days of study, the implantations cause a minor inflammatory response, which can be regarded as a normal defence mechanism. The sustained release performance of NTX from the biodegradable depot systems may provide a reliable, convenient, and safe mechanism for the administration of NTX for the long-term treatment of opioid dependence.
Similar articles
-
Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.Pharm Dev Technol. 2014 Jun;19(4):385-94. doi: 10.3109/10837450.2013.784334. Epub 2013 Apr 16. Pharm Dev Technol. 2014. PMID: 23590187
-
Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.Drug Dev Ind Pharm. 2011 Jun;37(6):673-84. doi: 10.3109/03639045.2010.535540. Epub 2011 Mar 30. Drug Dev Ind Pharm. 2011. PMID: 21449706 Free PMC article.
-
Preparation of biodegradable microspheres and matrix devices containing naltrexone.AAPS PharmSciTech. 2003;4(3):E34. doi: 10.1208/pt040334. AAPS PharmSciTech. 2003. PMID: 14621966 Free PMC article.
-
Naltrexone: a review of existing sustained drug delivery systems and emerging nano-based systems.J Control Release. 2014 Jun 10;183:154-66. doi: 10.1016/j.jconrel.2014.03.046. Epub 2014 Apr 2. J Control Release. 2014. PMID: 24704710 Review.
-
Biodegradable microspheres in drug delivery.Crit Rev Ther Drug Carrier Syst. 1995;12(1):1-99. doi: 10.1615/critrevtherdrugcarriersyst.v12.i1.10. Crit Rev Ther Drug Carrier Syst. 1995. PMID: 8521523 Review.
Cited by
-
Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.PLoS One. 2012;7(12):e52812. doi: 10.1371/journal.pone.0052812. Epub 2012 Dec 26. PLoS One. 2012. PMID: 23300784 Free PMC article.
-
Endogenous opiates and behavior: 2006.Peptides. 2007 Dec;28(12):2435-513. doi: 10.1016/j.peptides.2007.09.002. Epub 2007 Sep 11. Peptides. 2007. PMID: 17949854 Free PMC article. Review.
-
Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.Biomed Res Int. 2017;2017:7120815. doi: 10.1155/2017/7120815. Epub 2017 May 18. Biomed Res Int. 2017. PMID: 28607934 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources